The Valens Company Inc (VLNS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | VLNS | ABT | MDT | SYK | BSX |
| Company | The Valens Company Inc | Abbott Laboratories | Medtronic Inc | Stryker Corp | Boston Scientific Corp |
| Price Information | |||||
| Exchange | NASDAQ | NYSE | NYSE | NYSE | NYSE |
| Open | 0.7512 | 113.75 | 89.48 | 364.82 | 83.56 |
| High | 0.7745 | 114.16 | 89.59 | 366.59 | 84.04 |
| Low | 0.7479 | 113.20 | 88.74 | 362.60 | 83.10 |
| Last | 0.7602 | 113.70 | 89.34 | 364.81 | 83.92 |
| Change | +0.0002 | -0.45 | -0.13 | -0.24 | +0.21 |
| % Change | +0.03% | -0.39% | -0.15% | -0.07% | +0.25% |
| Volume | 44,600 | 8,402,978 | 25,369,152 | 1,751,582 | 6,966,911 |
| 20-Day Average Volume | 174,735 | 4,612,239 | 7,309,732 | 1,144,154 | 5,192,105 |
| Previous Close | 0.7600 | 114.15 | 89.47 | 365.05 | 83.71 |
| Industry | Medical Products | Medical Products | Medical Products | Medical Products | Medical Products |
| Has Options | No | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 0.6990 | 114.76 | 89.43 | 361.84 | 81.93 |
| 20-Day Raw Stochastic | 73.96% | 27.22% | 49.53% | 59.90% | 84.75% |
| 20-Day Relative Strength | 51.25% | 53.54% | 59.56% | 60.84% | 65.95% |
| Weighted Alpha | -63.26 | +15.09 | +14.36 | +27.92 | +57.83 |
| Today's Opinion | 56% Sell | 64% Buy | 72% Buy | 100% Buy | 100% Buy |
| Previous Opinion | 56% Sell | 72% Buy | 88% Buy | 100% Buy | 100% Buy |
| Last Month's Opinion | 8% Buy | 40% Buy | 24% Buy | 40% Buy | 88% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | +5.83% since 01/06/23 | -2.32% since 09/13/24 | -0.73% since 09/13/24 | -1.47% since 09/13/24 | +0.73% since 09/13/24 |
| Low | 0.6802 on 01/09/23 | 113.20 on 09/20/24 | 87.67 on 09/18/24 | 359.66 on 09/18/24 | 81.54 on 09/17/24 |
| High | 0.7745 on 01/13/23 | 118.54 on 09/17/24 | 90.24 on 09/16/24 | 374.63 on 09/16/24 | 84.89 on 09/19/24 |
| 1-Month | |||||
| %Chg | -5.88% since 12/13/22 | +2.65% since 08/20/24 | +4.64% since 08/20/24 | +6.38% since 08/20/24 | +6.93% since 08/20/24 |
| Low | 0.6000 on 01/03/23 | 110.68 on 08/21/24 | 85.86 on 08/21/24 | 342.54 on 08/21/24 | 78.29 on 08/21/24 |
| High | 0.8166 on 12/22/22 | 118.54 on 09/17/24 | 91.49 on 09/04/24 | 374.63 on 09/16/24 | 84.89 on 09/19/24 |
| 3-Month | |||||
| %Chg | +13.38% since 10/13/22 | +6.69% since 06/20/24 | +11.44% since 06/20/24 | +6.87% since 06/20/24 | +8.99% since 06/20/24 |
| Low | 0.6000 on 01/03/23 | 99.71 on 07/18/24 | 75.96 on 07/09/24 | 314.93 on 08/05/24 | 71.88 on 08/05/24 |
| High | 1.0900 on 12/05/22 | 118.54 on 09/17/24 | 91.49 on 09/04/24 | 374.63 on 09/16/24 | 84.89 on 09/19/24 |
| 6-Month | |||||
| %Chg | +6.50% since 07/13/22 | +1.97% since 03/20/24 | +6.31% since 03/20/24 | +3.29% since 03/20/24 | +24.44% since 03/20/24 |
| Low | 0.6000 on 01/03/23 | 99.71 on 07/18/24 | 75.96 on 07/09/24 | 314.93 on 08/05/24 | 66.80 on 04/22/24 |
| High | 1.2600 on 08/16/22 | 118.54 on 09/17/24 | 91.49 on 09/04/24 | 374.63 on 09/16/24 | 84.89 on 09/19/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 61,379 | 198,579,216 | 114,724,704 | 139,065,792 | 122,810,600 |
| Shares Outstanding, K | 80,740 | 1,739,634 | 1,282,270 | 380,950 | 1,467,096 |
| Annual Sales | 62,360,000 | 40,109,000,000 | 32,364,000,000 | 20,498,000,000 | 14,240,000,000 |
| Annual Net Income | -39,110,000 | 5,723,000,000 | 3,677,000,000 | 3,165,000,000 | 1,591,000,000 |
| Last Quarter Sales | 15,750,000 | 10,377,000,000 | 7,915,000,000 | 5,422,000,000 | 4,120,000,000 |
| Last Quarter Net Income | -21,360,000 | 1,302,000,000 | 1,043,000,000 | 825,000,000 | 324,000,000 |
| 60-Month Beta | N/A | 0.72 | 0.84 | 0.91 | 0.79 |
| Per-Share Information | |||||
| Most Recent Earnings | -0.19 on 10/13/22 | 1.14 on 07/18/24 | 1.23 on 08/20/24 | 2.81 on 07/30/24 | 0.62 on 07/24/24 |
| Latest Earnings Date | 02/27/23 | 10/16/24 | 08/20/24 | 11/07/24 | 10/24/24 |
| Most Recent Dividend | N/A | 0.550 on 07/15/24 | 0.700 on 06/27/24 | 0.800 on 06/28/24 | N/A |
| Next Ex-Dividends Date | N/A | 07/15/24 | 09/27/24 | 06/28/24 | N/A |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 25.82 | 16.82 | 32.18 | 37.03 |